Logo image of DYNT

DYNATRONICS CORP (DYNT) Stock Price, Forecast & Analysis

USA - NASDAQ:DYNT - US2681575005 - Common Stock

0.244 USD
+0.03 (+15.09%)
Last: 7/8/2024, 8:26:50 PM
0.2174 USD
-0.03 (-10.9%)
After Hours: 7/8/2024, 8:26:50 PM

DYNT Key Statistics, Chart & Performance

Key Statistics
Market Cap1.30M
Revenue(TTM)33.60M
Net Income(TTM)-5.13M
Shares5.31M
Float3.13M
52 Week High0.91
52 Week Low0.2
Yearly Dividend0
Dividend YieldN/A
EPS(TTM)-1.19
PEN/A
Fwd PEN/A
Earnings (Next)09-26 2024-09-26/amc
IPO1983-12-01
Sector
GICS SectorHealth Care
GICS IndustryHealth Care Equipment & Supplies
GICS IndustryGroupHealth Care Equipment & Services
GICS SubIndustryHealth Care Equipment


DYNT short term performance overview.The bars show the price performance of DYNT in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months -10 -20 -30 -40 -50

DYNT long term performance overview.The bars show the price performance of DYNT in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of DYNT is 0.244 USD. In the past month the price decreased by -39.15%. In the past year, price decreased by -68.32%.

DYNATRONICS CORP / DYNT Daily stock chart

DYNT Latest News, Press Relases and Analysis

DYNT Competitors/Peers

The largest stocks on the US markets in the "Health Care Equipment" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABT ABBOTT LABORATORIES25.32219.92B
ISRG INTUITIVE SURGICAL INC65.04200.75B
BSX BOSTON SCIENTIFIC CORP33.91148.20B
SYK STRYKER CORP27.03136.11B
IDXX IDEXX LABORATORIES INC56.1856.68B
BDX BECTON DICKINSON AND CO12.3350.97B
EW EDWARDS LIFESCIENCES CORP32.4548.96B
RMD RESMED INC25.436.70B
GEHC GE HEALTHCARE TECHNOLOGY15.9233.35B
PODD INSULET CORP69.9822.51B
DXCM DEXCOM INC29.5721.57B
ZBH ZIMMER BIOMET HOLDINGS INC10.9417.53B

About DYNT

Company Profile

DYNT logo image Dynatronics Corp. engages in the design, manufacture, and market of restorative products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company is headquartered in Salt Lake City, Utah and currently employs 154 full-time employees. The firm designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, the Company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The firm's products are marketed under a portfolio of brands, including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. Its orthopedic soft bracing products are designed to accelerate health for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury. The Company’s Solaris, Hausmann, PROTEAM, and Mammoth brands include products for physical therapy, rehabilitation, and athletic training.

Company Info

DYNATRONICS CORP

Bldg D, 7030 Park Centre Drive

Salt Lake City UTAH 55121 US

CEO: John A. Krier

Employees: 154

DYNT Company Website

Phone: 18015687000

DYNATRONICS CORP / DYNT FAQ

Can you describe the business of DYNATRONICS CORP?

Dynatronics Corp. engages in the design, manufacture, and market of restorative products for physical therapy, rehabilitation, orthopedics, pain management, and athletic training. The company is headquartered in Salt Lake City, Utah and currently employs 154 full-time employees. The firm designs, manufactures, and sells a range of products for clinical use in physical therapy, rehabilitation, orthopedics, pain management, and athletic training. Through its distribution channels, the Company markets and sells to orthopedists, physical therapists, chiropractors, athletic trainers, sports medicine practitioners, clinics, and hospitals. The firm's products are marketed under a portfolio of brands, including Bird & Cronin, Solaris, Hausmann, PROTEAM, and Mammoth, among others. Its orthopedic soft bracing products are designed to accelerate health for patients both pre- and post-surgical intervention, and during fracture recovery, joint stabilization, and ligament injury. The Company’s Solaris, Hausmann, PROTEAM, and Mammoth brands include products for physical therapy, rehabilitation, and athletic training.


What is the current price of DYNT stock?

The current stock price of DYNT is 0.244 USD. The price increased by 15.09% in the last trading session.


Does DYNATRONICS CORP pay dividends?

DYNT does not pay a dividend.


What is the ChartMill technical and fundamental rating of DYNT stock?

DYNT has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 1 out of 10.


How is the market expecting DYNT stock to perform?

7 analysts have analysed DYNT and the average price target is 4.08 USD. This implies a price increase of 1572.13% is expected in the next year compared to the current price of 0.244.


What is the employee count for DYNT stock?

DYNATRONICS CORP (DYNT) currently has 154 employees.


When does DYNATRONICS CORP (DYNT) report earnings?

DYNATRONICS CORP (DYNT) will report earnings on 2024-09-26, after the market close.


DYNT Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

DYNT Fundamental Analysis

ChartMill assigns a fundamental rating of 1 / 10 to DYNT. Both the profitability and financial health of DYNT have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

DYNT Financial Highlights

Over the last trailing twelve months DYNT reported a non-GAAP Earnings per Share(EPS) of -1.19. The EPS increased by 10.53% compared to the year before.


Industry RankSector Rank
PM (TTM) N/A
ROA -18.49%
ROE -34.58%
Debt/Equity 0.26
Chartmill High Growth Momentum
EPS Q2Q%52.78%
Sales Q2Q%-17.09%
EPS 1Y (TTM)10.53%
Revenue 1Y (TTM)-22.51%

DYNT Forecast & Estimates

7 analysts have analysed DYNT and the average price target is 4.08 USD. This implies a price increase of 1572.13% is expected in the next year compared to the current price of 0.244.

For the next year, analysts expect an EPS growth of 35.73% and a revenue growth -14.58% for DYNT


Analysts
Analysts82.86
Price Target4.08 (1572.13%)
EPS Next Y35.73%
Revenue Next Year-14.58%

DYNT Ownership

Ownership
Inst OwnersN/A
Ins Owners90.62%
Short Float %0.01%
Short Ratio0